KPC Pharmaceuticals Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares KPC Pharmaceuticals Inc with three other
companies in this sector in China:
JiangSu Bicon Pharmaceutical Listed Co
sales of 5.37 billion Chinese Renmimbi [US$852.60 million]
of which 46%
was Pharmaceutical Intermediates),
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
(5.69 billion Chinese Renmimbi [US$903.62 million]
Hubei Jumpcan Pharmaceutical Co Ltd
(5.64 billion Chinese Renmimbi [US$896.12 million]
of which 96%
KPC Pharmaceuticals Inc reported sales of 5.85 billion Chinese Renmimbi (US$929.52 million)
December of 2017.
increase of 14.7%
versus 2016, when the company's sales were 5.10 billion Chinese Renmimbi.
Sales at KPC Pharmaceuticals Inc have increased during each of the previous five years
(and since 2012, sales have increased a total of 94%).
Sales of Daily Necessities saw an increase
that was more than double the company's growth rate: sales were up
351.2% in 2017, from
956,636.43 Chinese Renmimbi to 4.32 million Chinese Renmimbi.
KPC Pharmaceuticals Inc also saw significant increases in sales in
Oral Agents (up 23.4% to 1.83 billion Chinese Renmimbi)
Injection (up 30.0% to 1.35 billion Chinese Renmimbi)
Medical Services (up 343.3% to 2.88 million Chinese Renmimbi)
Other (up 110.9% to 93.08 million Chinese Renmimbi)